当前位置: X-MOL首页最新SCI期刊查询及投稿分析系统 › Expert Review of Anticancer Therapy杂志
Expert Review of Anticancer Therapy
基本信息
期刊名称 Expert Review of Anticancer Therapy
EXPERT REV ANTICANC
期刊ISSN 1473-7140
期刊官方网站 http://www.tandfonline.com/toc/iery20/current#.V48dKEz9cSQ
是否OA
出版商 Taylor and Francis Ltd.
出版周期 Bimonthly
始发年份 2001
年文章数 113
最新影响因子 3.3(2022)  scijournal影响因子  greensci影响因子
中科院SCI期刊分区
大类学科 小类学科 Top 综述
医学4区 ONCOLOGY 肿瘤学4区
CiteScore
CiteScore排名 CiteScore SJR SNIP
学科 排名 百分位 2.14 0.881 0.612
Medicine
Pharmacology (medical)
91 / 232 60%
Medicine
Oncology
164 / 321 48%
补充信息
自引率 1.40%
H-index 55
SCI收录状况 Science Citation Index Expanded
官方审稿时间
网友分享审稿时间 数据统计中,敬请期待。
PubMed Central (PML) http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1473-7140%5BISSN%5D
投稿指南
期刊投稿网址 https://mc.manuscriptcentral.com/ert
收稿范围

Expert Review of Anticancer Therapy (ISSN 1473-7140) provides expert appraisal and commentary on the major trends in cancer care and highlights the performance of new therapeutic and diagnostic approaches. 
  
Coverage includes tumor management, novel medicines, anticancer agents and chemotherapy, biological therapy, cancer vaccines, therapeutic indications, biomarkers and diagnostics, and treatment guidelines. All articles are subject to rigorous peer-review, and the journal makes an essential contribution to decision-making in cancer care. 
  
Comprehensive coverage in each review is complemented by the unique Expert Review format and includes the following sections: 
 

Expert Opinion - a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results

Article Highlights – an executive summary of the author’s most critical points 


收录体裁
投稿指南
投稿模板
参考文献格式
编辑信息

Editor-in-Chief: Gertjan JL Kaspers , VU Uni. Med. Center, The Netherlands 


Richard J Ablin , Arizona Cancer Center, USA 

Jame Abraham , Cleveland Clinic, USA 

Michael B Atkins, Beth Israel Deaconess Med. Center, USA  

Jean-Yves Blay, Leon Berard Center, Claude Bernard University, Lyon, France

Alba A. Brandes, AUSL Bologna, Italy 

James Cassidy , Beatson Oncology Center, UK 

Liang Cheng , Indiana Uni. School of Medicine, USA 

Angus G Dalgleish , St George’s Hospital, UK 

William S Dalton , Lee Moffitt Cancer Ctr & Res. Inst., USA

Theo M. De Reijke, Academic Medical Center, The Netherlands

Kapil Dhingra , Hoffman-La Roche, USA

David S. Ettinger , Johns Hopkins Oncology Center, USA 

Alfio Ferlito , University of Udine, Italy 

Apar Kishor Ganti , Nebraska Medical Center, USA

Antonio J Grillo-Lopez , Clinical Research, USA 

Peter J Hersey , University of Newcastle, Australia 

Eiso Hiyama , Hiroshima University, Japan 

Thomas E Hutson , Baylor Sammons Cancer Center, TX, USA 

David H Ilson  , Memorial Sloan Kettering Cancer Center, USA

Ashish M Kamat, MD Anderson Cancer Center, USA  

Simon S Lo , Case Western Reserve University Comprehensive Cancer Center, USA 

Hitendra HR Patel , University College London, UK 

Vipul R Patel , The Ohio State University, OH, USA 

Marshall R Posner , Dana-Farber Cancer Institute, USA  

Timothy Price , The Queen Elizabeth Hospital, Australia 

Nagahiro Saijo , National Cancer Center Hospital, Japan 

Edgardo Santos , University of Miami Miller School of Medicine, USA 

Dong Moon Shin , University of Pittsburgh Cancer Inst., USA 

Giuseppe Tonini , University Campus Bio-Medico, Italy 

Allan Van Oosterom , Uni. Hosp. Gasthuisberg, Belgium

Nico Van Zandwijk , Sydney Medical School, Australia 

Jan B Vermorken , University Hospital, Belgium 

Louis M Weiner , Fox Chase Cancer Center, USA 

Christine A White , IDEC Pharmaceuticals, USA 

Sam M Wiseman , Uni. British Columbia, Canada 

Paul Workman , Institute of Cancer Research, UK 

Jerome B Zeldis, Celgene, USA 


我要分享  (欢迎您来完善期刊的资料,分享您的实际投稿经验)
研究领域:
投稿录用情况: 审稿时间:  个月返回审稿结果
本次投稿点评:
提交
down
wechat
bug